Liberate Bio

Seed
liberatebio.com Biotech & Healthcare Boston, United States
Total Funding $31M
Latest Round $31M Seed
Last Announced Oct 15, 2025
Investors 1 Backer
Decision Makers 6 Available

About Liberate Bio

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Boston, United States
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website liberatebio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $31,000,000 · Seed

    fundraisingfox.com

Investors & Backers

1
Khosla Ventures

Funding History

1 Round
Seed equity · Oct 15, 2025

Founders & Leadership

6

Michael Mitchell

CO-FOUNDER, UNIVERSITY OF PENNSYLVANIA

Work email & phone locked Unlock →

Nessan Bermingham

CO-FOUNDER, KHOSLA VENTURES

Work email & phone locked Unlock →

Shawn Davis

Chief Executive Officer

Work email & phone locked Unlock →

Stephen Scully

Founder

Work email & phone locked Unlock →

Steven Bernstein

Chief Medical Officer

Work email & phone locked Unlock →

Theresa M. Reineke

CO-FOUNDER, UNIVERSITY OF MINNESOTA

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts